Objective:

To investigate the association of human umbilical cord mesenchymal stem cell-derived exosomes (hUCMSC-Exos) with changes in renal injury markers, gut microbiota diversity, and inflammatory pathways in IgA nephropathy (IgAN), focusing on specific parameters such as renal function and immune responses.

Key Findings:

• hUCMSC-Exos were associated with significant changes in renal injury markers in IgAN-like mice.
• Alterations in gut microbial composition were observed, shifting towards a profile closer to controls, with specific taxa such as Anaerostipes, Dorea, and Ruminococcus showing notable changes.
• Specific bacterial taxa correlated with renal dysfunction indicators and inflammatory markers, highlighting their potential role in disease pathology.
• Transcriptomic analysis revealed altered expression of NLRP3 inflammasome-related genes and AhR-related signaling components, suggesting a complex interplay in inflammatory responses.
• In vitro, hUCMSC-Exos reduced levels of NLRP3, IL-1β, and IL-18 in Gd-IgA1-stimulated podocytes, indicating a potential therapeutic effect.

Interpretation:

The findings suggest a potential association between gut microbiota, innate immune-related signaling, and renal injury in IgAN, with hUCMSC-Exos as a candidate for further investigation, particularly in therapeutic contexts.

Limitations:

• Observations are descriptive and associative; causal mechanisms cannot be inferred, necessitating further experimental validation.
• Further validation is required for the context-dependent inflammatory activity suggested by transcriptomic analysis, particularly in diverse patient populations.

Conclusion:

hUCMSC-Exos may represent a promising avenue for further research in the context of IgAN, warranting deeper exploration into their therapeutic potential.